Proliferative GN is classified as
immune complex-mediated or
complement-mediated (C3 glomerulopathy).
Immune complex-mediated GN results from glomerular deposition of
immune-complexes/Ig and C3; the C3 is derived from activation of the classical and/or
lectin pathways of
complement. C3 glomerulopathy results from deposition of C3 and other
complement fragments with minimal or no deposition of
immune complexes/Ig; the C3 is derived from activation of the alternative pathway of
complement. C4d is a byproduct of activation of the classic and
lectin pathways. Although widely used as a marker for antibody-mediated rejection, the significance of C4d in C3 glomerulopathy is undetermined. We studied glomerular C4d staining in 18 biopsy specimens of
immune-complex GN, 30 biopsy specimens of C3 GN, and 13 biopsy specimens of postinfectious GN. All specimens of
immune complex-mediated GN, except two specimens of
IgA nephropathy and one specimen of sclerosing membranoproliferative GN, showed bright (2-3+) C4d staining. The staining pattern of C4d mirrored the staining patterns of Ig and C3. Conversely, C4d staining was completely negative in 24 (80%) of 30 specimens of C3 glomerulopathy, and only trace/1+ C4d staining was detected in six (20%) specimens. With regard to postinfectious GN, C4d staining was negative in six (46%) of 13 specimens, suggesting an abnormality in the alternative pathway, and it was positive in seven (54%) specimens. To summarize, C4d serves as a positive marker for
immune complex-mediated GN but is absent or minimally detected in C3 glomerulopathy.